Inhibition of the CXCR3-mediated pathway suppresses ultraviolet B-induced pigmentation and erythema in skin

British Journal of Dermatology

Volumn 163, Issue 3, 2010, Pages 593-602

  Kurata, R ^a,b   Fujita, F ^a   Oonishi, K ^a   Kuriyama, K I ^a   Kawamata, S ^b  

^a C   (Japan)

^b FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

Author keywords

CXCR3; erythema; interferon ; Paeonia suffruticosa Andrews; pigmentation; ultraviolet B

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MESSENGER RNA; PAEONIA SUFFRUTICOSA EXTRACT; SHORT HAIRPIN RNA;

ABSENCE OF SIDE EFFECTS; ARTICLE; CONTROLLED STUDY; ERYTHEMA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE REPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; LENTIVIRINAE; MELANOGENESIS; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING TEST; SIGNAL TRANSDUCTION; SKIN PIGMENTATION; SUNBURN; ULTRAVIOLET B RADIATION;

CELLS, CULTURED; CHEMOKINE CXCL10; CHEMOKINE CXCL11; DERMATITIS; ERYTHEMA; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA; KERATINOCYTES; MELANINS; MICROARRAY ANALYSIS; PAEONIA; PLANT PREPARATIONS; RECEPTORS, CXCR; RECEPTORS, CXCR3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; SKIN PIGMENTATION; SUNBURN; ULTRAVIOLET RAYS; UP-REGULATION;

EID: 77955915944     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09850.x     Document Type: Article

References (34)

1. Gilchrest BA, Park HY, Eller MS et al. Mechanisms of ultraviolet light-induced pigmentation. Photochem Photobiol 1996 63:1 10.
2. Hearing VJ, Jimenez M. Mammalian tyrosinase - the critical regulatory control point in melanocyte pigmentation. Int J Biochem 1987 19:1141 1147.
3. Pawelek JM. Factors regulating growth and pigmentation of melanoma cells. J Invest Dermatol 1976 66:201 209.
4. Yoshida M, Takahashi Y, Inoue S. Histamine induces melanogenesis and morphologic changes by protein kinase A activation via H2 receptors in human normal melanocytes. J Invest Dermatol 2000 114:334 342.
5. Prunieras M. Melanocytes, melanogenesis, and inflammation. Int J Dermatol 1986 25:624 628.
6. Ulrich C, Schmook T, Sachse MM et al. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients. Dermatol Surg 2004 30:622 627.
7. Whitman GB, Leach EE, DeLeo VA et al. Comparative study of erythema response to UVA radiation in guinea pigs and humans. Photochem Photobiol 1985 42:399 403.
8. Fitzpatrick TB. Ultraviolet-induced pigmentary changes: benefits and hazards. Curr Probl Dermatol 1986 15:25 38.
9. Diffey BL, Oakley AM. The onset of ultraviolet erythema. Br J Dermatol 1987 116:183 187.
10. Takiwaki H, Shirai S, Kohno H et al. The degrees of UVB-induced erythema and pigmentation correlate linearly and are reduced in a parallel manner by topical anti-inflammatory agents. J Invest Dermatol 1994 103:642 646.
11. Halaban R, Langdon R, Birchall N et al. Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes. J Cell Biol 1988 107:1611 1619.
12. Tasaka K, Kamei C, Nakano S et al. Effects of certain resorcinol derivatives on the tyrosinase activity and the growth of melanoma cells. Methods Find Exp Clin Pharmacol 1998 20:99 109.
13. Imokawa G, Miyagishi M, Yada Y. Endothelin-1 as a new melanogen: coordinated expression of its gene and the tyrosinase gene in UVB-exposed human epidermis. J Invest Dermatol 1995 105:32 7.
14. Nordlund JJ, Collins CE, Rheins LA. Prostaglandin E2 and D2 but not MSH stimulate the proliferation of pigment cells in the pinnal epidermis of the DBA2 mouse. J Invest Dermatol 1986 86:433 437.
15. Tomonari S, Migita K, Takagi A et al. Expression patterns of the opsin 5-related genes in the developing chicken retina. Dev Dyn 2008 237:1910 1922.
16. Mudgil AV, Segal N, Andriani F et al. Ultraviolet B irradiation induces expansion of intraepithelial tumor cells in a tissue model of early cancer progression. J Invest Dermatol 2003 121:191 197.
17. Yarosh D, Both D, Kibitel J et al. Regulation of TNFalpha production and release in human and mouse keratinocytes and mouse skin after UVB irradiation. Photodermatol Photoimmunol Photomed 2000 16:263 270.
18. Feldmeyer L, Keller M, Niklaus G et al. The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes. Curr Biol 2007 17:1140 1145.
19. Szulc J, Wiznerowicz M, Sauvain MO et al. A versatile tool for conditional gene expression and knockdown. Nat Methods 2006 3:109 116.
20. Murphy PM, Baggiolini M, Charo IF et al. International Union of Pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000 52:145 176.
21. Arenberg DA, Zlotnick A, Strom SR et al. The murine CC chemokine, 6C-kine, inhibits tumor growth and angiogenesis in a human lung cancer SCID mouse model. Cancer Immunol Immunother 2001 49:587 592.
22. Luster AD, Ravetch JV. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med 1987 166:1084 1097.
23. Flier J, Boorsma DM, Bruynzeel DP et al. The CXCR3 activating chemokines IP-10, Mig, and IP-9 are expressed in allergic but not in irritant patch test reactions. J Invest Dermatol 1999 113:574 578.
24. Flier J, Boorsma DM, van Beek PJ et al. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J Pathol 2001 194:398 405.
25. Cole AM, Ganz T, Liese AM et al. Cutting edge: IFN-inducible ELR-CXC chemokines display defensin-like antimicrobial activity. J Immunol 2001 167:623 627.
26. Stanford MM, Issekutz TB. The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo. J Leukoc Biol 2003 74:791 799.
27. Watson RJ, Allen DR, Birch HL et al. Development of CXCR3 antagonists. Part 2: identification of 2-amino(4-piperidinyl)azoles as potent CXCR3 antagonists. Bioorg Med Chem Lett 2007 17:6806 6810.
28. Aoki H, Moro O. Upregulation of the IFN-gamma-stimulated genes in the development of delayed pigmented spots on the dorsal skin of F1 mice of HR-1 × HRDe. J Invest Dermatol 2005 124:1053 1061.
29. Chen G, Zhang L, Zhu Y. Determination of glycosides and sugars in Moutan Cortex by capillary electrophoresis with electrochemical detection. J Pharm Biomed Anal 2006 41:129 134.
30. Li Y, Zhang W, Huang L, Shi J. [Pharmacology of cortex moutan and core]. Zhongguo Zhong Yao Za Zhi 1997 22:214 216, 254.
31. Ma CX, Fang LG, Liu GL. [Changes in intra-articular pressure of the hip joint in Legg-Perthes disease]. Zhonghua Wai Ke Za Zhi 1984 22:755 756, 783.
32. Rho S, Chung HS, Kang M et al. Inhibition of production of reactive oxygen species and gene expression profile by treatment of ethanol extract of Moutan Cortex Radicis in oxidative stressed PC12 cells. Biol Pharm Bull 2005 28:661 666.
33. Yoshikawa M, Uchida E, Kawaguchi A et al. Galloyl-oxypaeoniflorin, suffruticosides A, B, C, and D, five new antioxidative glycosides, and suffruticoside E, a paeonol glycoside, from Chinese moutan cortex. Chem Pharm Bull (Tokyo) 1992 40:2248 2250.
34. Wu M, Gu Z. Screening of bioactive compounds from moutan cortex and their anti-inflammatory activities in rat synoviocytes. Evid Based Complement Alternat Med 2009 6:57 63.